Global DNA Vaccines Market Research Report 2019


    Table of Contents

      Executive Summary

        1 DNA Vaccines Market Overview

        • 1.1 Product Overview and Scope of DNA Vaccines
        • 1.2 DNA Vaccines Segment By type
          • 1.2.1 Global DNA Vaccines Production Growth Rate Comparison By type (2014-2025)
          • 1.2.2 Human DNA vaccines
          • 1.2.3 Animal DNA vaccines
        • 1.3 DNA Vaccines Segment by Application
          • 1.3.1 DNA Vaccines Consumption Comparison by Application (2014-2025)
          • 1.3.2 Human health
          • 1.3.3 Animal health
          • 1.3.4 Research application
        • 1.4 Global DNA Vaccines Market by Region
          • 1.4.1 Global DNA Vaccines Market Size Region
          • 1.4.2 North America Status and Prospect (2014-2025)
          • 1.4.3 Europe Status and Prospect (2014-2025)
          • 1.4.4 China Status and Prospect (2014-2025)
          • 1.4.5 Japan Status and Prospect (2014-2025)
        • 1.5 Global DNA Vaccines Market Size
          • 1.5.1 Global DNA Vaccines Revenue (2014-2025)
          • 1.5.2 Global DNA Vaccines Production (2014-2025)

        2 Global DNA Vaccines Market Competition by Manufacturers

        • 2.1 Global DNA Vaccines Production Market Share by Manufacturers (2014-2019)
        • 2.2 Global DNA Vaccines Revenue Share by Manufacturers (2014-2019)
        • 2.3 Global DNA Vaccines Average Price by Manufacturers (2014-2019)
        • 2.4 Manufacturers DNA Vaccines Production Sites, Area Served, Product Types
        • 2.5 DNA Vaccines Market Competitive Situation and Trends
          • 2.5.1 DNA Vaccines Market Concentration Rate
          • 2.5.2 DNA Vaccines Market Share of Top 3 and Top 5 Manufacturers
          • 2.5.3 Mergers & Acquisitions, Expansion

        3 Global DNA Vaccines Production Market Share by Regions

        • 3.1 Global DNA Vaccines Production Market Share by Regions
        • 3.2 Global DNA Vaccines Revenue Market Share by Regions (2014-2019)
        • 3.3 Global DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.4 North America DNA Vaccines Production
          • 3.4.1 North America DNA Vaccines Production Growth Rate (2014-2019)
          • 3.4.2 North America DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.5 Europe DNA Vaccines Production
          • 3.5.1 Europe DNA Vaccines Production Growth Rate (2014-2019)
          • 3.5.2 Europe DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.6 China DNA Vaccines Production (2014-2019)
          • 3.6.1 China DNA Vaccines Production Growth Rate (2014-2019)
          • 3.6.2 China DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.7 Japan DNA Vaccines Production (2014-2019)
          • 3.7.1 Japan DNA Vaccines Production Growth Rate (2014-2019)
          • 3.7.2 Japan DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

        4 Global DNA Vaccines Consumption by Regions

        • 4.1 Global DNA Vaccines Consumption by Regions
        • 4.2 North America DNA Vaccines Consumption (2014-2019)
        • 4.3 Europe DNA Vaccines Consumption (2014-2019)
        • 4.4 China DNA Vaccines Consumption (2014-2019)
        • 4.5 Japan DNA Vaccines Consumption (2014-2019)

        5 Global DNA Vaccines Production, Revenue, Price Trend by Type

        • 5.1 Global DNA Vaccines Production Market Share by Type (2014-2019)
        • 5.2 Global DNA Vaccines Revenue Market Share by Type (2014-2019)
        • 5.3 Global DNA Vaccines Price by Type (2014-2019)
        • 5.4 Global DNA Vaccines Production Growth by Type (2014-2019)

        6 Global DNA Vaccines Market Analysis by Applications

        • 6.1 Global DNA Vaccines Consumption Market Share by Application (2014-2019)
        • 6.2 Global DNA Vaccines Consumption Growth Rate by Application (2014-2019)

        7 Company Profiles and Key Figures in DNA Vaccines Business

        • 7.1 Sanofi Aventis
          • 7.1.1 Sanofi Aventis DNA Vaccines Production Sites and Area Served
          • 7.1.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.1.3 Sanofi Aventis DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.1.4 Main Business and Markets Served
        • 7.2 Pfizer
          • 7.2.1 Pfizer DNA Vaccines Production Sites and Area Served
          • 7.2.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.2.3 Pfizer DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.2.4 Main Business and Markets Served
        • 7.3 Novartis
          • 7.3.1 Novartis DNA Vaccines Production Sites and Area Served
          • 7.3.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.3.3 Novartis DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.3.4 Main Business and Markets Served
        • 7.4 Merck
          • 7.4.1 Merck DNA Vaccines Production Sites and Area Served
          • 7.4.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.4.3 Merck DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.4.4 Main Business and Markets Served
        • 7.5 GlaxoSmithKline
          • 7.5.1 GlaxoSmithKline DNA Vaccines Production Sites and Area Served
          • 7.5.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.5.3 GlaxoSmithKline DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.5.4 Main Business and Markets Served
        • 7.6 ABL
          • 7.6.1 ABL DNA Vaccines Production Sites and Area Served
          • 7.6.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.6.3 ABL DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.6.4 Main Business and Markets Served
        • 7.7 Immunologicals
          • 7.7.1 Immunologicals DNA Vaccines Production Sites and Area Served
          • 7.7.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.7.3 Immunologicals DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.7.4 Main Business and Markets Served
        • 7.8 Xenetic Biosciences
          • 7.8.1 Xenetic Biosciences DNA Vaccines Production Sites and Area Served
          • 7.8.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.8.3 Xenetic Biosciences DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.8.4 Main Business and Markets Served
        • 7.9 QED Biosciences
          • 7.9.1 QED Biosciences DNA Vaccines Production Sites and Area Served
          • 7.9.2 DNA Vaccines Product Introduction, Application and Specification
          • 7.9.3 QED Biosciences DNA Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.9.4 Main Business and Markets Served

        8 DNA Vaccines Manufacturing Cost Analysis

        • 8.1 DNA Vaccines Key Raw Materials Analysis
          • 8.1.1 Key Raw Materials
          • 8.1.2 Price Trend of Key Raw Materials
          • 8.1.3 Key Suppliers of Raw Materials
        • 8.2 Proportion of Manufacturing Cost Structure
        • 8.3 Manufacturing Process Analysis of DNA Vaccines
        • 8.4 DNA Vaccines Industrial Chain Analysis

        9 Marketing Channel, Distributors and Customers

        • 9.1 Marketing Channel
          • 9.1.1 Direct Marketing
          • 9.1.2 Indirect Marketing
        • 9.2 DNA Vaccines Distributors List
        • 9.3 DNA Vaccines Customers

        10 Market Dynamics

        • 10.1 Market Trends
        • 10.2 Opportunities
        • 10.3 Market Drivers
        • 10.4 Challenges
        • 10.5 Influence Factors

        11 Global DNA Vaccines Market Forecast

        • 11.1 Global DNA Vaccines Production, Revenue Forecast
          • 11.1.1 Global DNA Vaccines Production Growth Rate Forecast (2019-2025)
          • 11.1.2 Global DNA Vaccines Revenue and Growth Rate Forecast (2019-2025)
          • 11.1.3 Global DNA Vaccines Price and Trend Forecast (2019-2025)
        • 11.2 Global DNA Vaccines Production Forecast by Regions (2019-2025)
          • 11.2.1 North America DNA Vaccines Production, Revenue Forecast (2019-2025)
          • 11.2.2 Europe DNA Vaccines Production, Revenue Forecast (2019-2025)
          • 11.2.3 China DNA Vaccines Production, Revenue Forecast (2019-2025)
          • 11.2.4 Japan DNA Vaccines Production, Revenue Forecast (2019-2025)
        • 11.3 Global DNA Vaccines Consumption Forecast by Regions (2019-2025)
          • 11.3.1 North America DNA Vaccines Consumption Forecast (2019-2025)
          • 11.3.2 Europe DNA Vaccines Consumption Forecast (2019-2025)
          • 11.3.3 China DNA Vaccines Consumption Forecast (2019-2025)
          • 11.3.4 Japan DNA Vaccines Consumption Forecast (2019-2025)
        • 11.4 Global DNA Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
        • 11.5 Global DNA Vaccines Consumption Forecast by Application (2019-2025)

        12 Research Findings and Conclusion

          13 Methodology and Data Source

          • 13.1 Methodology/Research Approach
            • 13.1.1 Research Programs/Design
            • 13.1.2 Market Size Estimation
            • 13.1.3 Market Breakdown and Data Triangulation
          • 13.2 Data Source
            • 13.2.1 Secondary Sources
            • 13.2.2 Primary Sources
          • 13.3 Author List

          A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines.
          The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity.

          The global DNA Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
          This report focuses on DNA Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall DNA Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
          At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

          The following manufacturers are covered:
          Sanofi Aventis
          Pfizer
          Novartis
          Merck
          GlaxoSmithKline
          ABL
          Immunologicals
          Xenetic Biosciences
          QED Biosciences

          Segment by Regions
          North America
          Europe
          China
          Japan

          Segment by Type
          By type
          Human DNA vaccines
          Animal DNA vaccines
          By technology
          pDNA vaccines technology
          pDNA delivery technology

          Segment by Application
          Human health
          Animal health
          Research application



          Summary:
          DNA Vaccines Market Research Reports - DNA Vaccines Market Analysis, Trends & Statistics. Industry analysis and Market Report on DNA Vaccines is a syndicated market report, published as DNA Vaccines . It is complete Research Study and Industry Analysis of DNA Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.



          REPORT YOU MIGHT BE INTERESTED